India's Gennova developing Omicron-specific COVID-19 vaccine Pfizer Inc said last week a redesigned COVID-19 vaccine that specifically targets the Omicron coronavirus variant could be ready to launch by March. World 17 Jan, 2022
Sanofi, GSK say COVID-19 vaccine booster candidate give good immune response Sanofi and GlaxoSmithKline said on Wednesday a single booster dose of their COVID-19 vaccine candidate provided strong immune responses, preliminary data from clinical trials show, a boost for the drugmakers after lagging the vaccine race. COVID-19 15 Dec, 2021
Int'l Vaccine Institute to lead clinical trial in Nepal Sanofi and GSK received approval for their Phase 3 clinical study in Nepal to assess the safety, efficacy, and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine candidate. Nepal 01 Oct, 2021
Novavax to deliver 350 mln COVID-19 vaccine doses to COVAX scheme The COVAX facility, a global initiative aimed at equitable access to COVID-19 vaccines for poorer countries, is co-led by GAVI, the World Health Organization and the Coalition for Epidemic Preparedness Innovations. World 06 May, 2021
New variants of COVID-19: What if they hit the world again? We do have the bitter experience of not being able to develop a dengue vaccine till date. The reason behind this is the presence of multiple serotypes. When there is an infection of one serotype, it may confer safety to that serotype but not to others.... 07 Jan, 2021
Philippines to get 30 mln doses of Novavax COVID-19 vaccine: minister MANILA: The Philippines expects to receive 30 million doses of Novavax Inc's COVID-19 vaccine by July next year, its foreign minister said on Monday, boosting the country's effort to secure supplies to inoculate more than 100 million... Women 21 Dec, 2020
UK secures 2 mln more doses of Moderna's COVID-19 vaccine Britain has secured two million doses of Moderna Inc's COVID-19 vaccine candidate, to be available in Europe as early as the spring, the government said on Sunday, in addition to the 5 million doses it secured from the US company two weeks... Women 29 Nov, 2020
Nepal on priority for COVID-19 vaccine: Shringla KATHMANDU, NOVEMBER 27 Indian Foreign Secretary Harsh Vardhan Shringla has assured the people of Nepal that, once a COVID-19 vaccine is rolled out in India, meeting Nepal’s requirements would be a priority for India. Addressing a talk programme... Travel 28 Nov, 2020
Pfizer, BioNTech seek emergency use of COVID-19 shots in US Pfizer formally asked US regulators Friday to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long,... Environment 21 Nov, 2020
South African firm and Johnson & Johnson strike vaccine deal JOHANNESBURG: South African pharmaceutical firm Aspen Pharmacare has announced a deal with U.S. firm Johnson & Johnson to manufacture its COVID-19 vaccine candidate, if it is approved in South Africa and internationally. In a statement issued on... Environment 03 Nov, 2020
Worldwide�coronavirus�cases�cross 37.74 million, death toll at 1,078,572 More than 37.74 million people have been reported to be infected by the novel coronavirus globally and 1,078,572 have died, according to a Reuters tally. Johnson & Johnson said it had temporarily paused its COVID-19 vaccine candidate clinical... Women 13 Oct, 2020
2nd COVID-19 vaccine trial paused over unexplained illness NEW BRUNSWICK: A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot. The company said in a... Environment 13 Oct, 2020
